董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Liam Kelly | 男 | Chairman, President and Chief Executive Officer | 57 | 819.05万美元 | 30.56 | 2024-02-23 |
| Candace H. Duncan | 女 | Director | 70 | 31.38万美元 | 1.73 | 2024-02-23 |
| John C. Heinmiller | 男 | Director | 69 | 26.19万美元 | 0.90 | 2024-02-23 |
| Neena M. Patil | 女 | Director | 49 | 31.72万美元 | 0.23 | 2024-02-23 |
| Jaewon Ryu | -- | Director | -- | 未披露 | 未持股 | 2024-02-23 |
| Stuart A. Randle | 男 | Director | 65 | 28.33万美元 | 1.54 | 2024-02-23 |
| Andrew A. Krakauer | 男 | Director | 69 | 27.04万美元 | 1.17 | 2024-02-23 |
| Stephen K. Klasko | 男 | Director | 71 | 26.74万美元 | 1.90 | 2024-02-23 |
| Gretchen R. Haggerty | 女 | Director | 68 | 28.73万美元 | 1.34 | 2024-02-23 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Liam Kelly | 男 | Chairman, President and Chief Executive Officer | 57 | 819.05万美元 | 30.56 | 2024-02-23 |
| Cameron P. Hicks | 男 | Corporate Vice President, Human Resources and Communications | 59 | 134.32万美元 | 未持股 | 2024-02-23 |
| John R. Deren | -- | Corporate Vice President and Chief Accounting Officer | -- | 未披露 | 未持股 | 2024-02-23 |
| James Winters | 男 | Corporate Vice President, Manufacturing and Supply Chain | 51 | 140.91万美元 | 1.76 | 2024-02-23 |
| Daniel V. Logue | 男 | Corporate Vice President, General Counsel and Secretary | 50 | 未披露 | 2.70 | 2024-02-23 |
| Jay White | 男 | Corporate Vice President and President, Global Commercial | 50 | 215.57万美元 | 3.56 | 2024-02-23 |
| Thomas E. Powell | 男 | Executive Vice President and Chief Financial Officer | 62 | 328.12万美元 | 15.13 | 2024-02-23 |
董事简历
中英对照 | 中文 | 英文- Liam Kelly
-
Liam Kelly，2012年6月起担任执行副总裁和国际总裁。此前，他在公司EMEA部担任数个职位，包括2011年6月至2012年6月任总裁；2009年11月至2011年6月任执行副总裁；2009年4月至11月任市场营销副总裁。加入Teleflex前，2002年10月至2009年8月，他在医疗设备公司Hill-Rom Holdings, Inc.担任多个高级职位，其中，2006年8月至2009年2月担任国际市场营销和研发部副总裁。
Liam Kelly,has been Teleflex Incorporated President and Chief Executive Officer since January 2018 and has been Chairman of Teleflex Incorporated Board of Directors since May 2020. From May 2016 to December 31, 2017, Mr. Kelly served as Teleflex Incorporated President and Chief Operating Officer. From April 2015 to April 2016, he served as Executive Vice President and Chief Operating Officer. From April 2014 to April 2015, Mr. Kelly served as Executive Vice President and President, Americas. From June 2012 to April 2014 Mr. Kelly served as Executive Vice President and President, International. He also has held several positions with regard to Teleflex Incorporated EMEA segment, including President from June 2011 to June 2012, Executive Vice President from November 2009 to June 2011, and Vice President of Marketing from April 2009 to November 2009. Prior to joining Teleflex, Mr. Kelly held various senior level positions with Hill-Rom Holdings, Inc., a medical device company, from October 2002 to April 2009, serving as its Vice President of International Marketing and R&D from August 2006 to February 2009. - Liam Kelly，2012年6月起担任执行副总裁和国际总裁。此前，他在公司EMEA部担任数个职位，包括2011年6月至2012年6月任总裁；2009年11月至2011年6月任执行副总裁；2009年4月至11月任市场营销副总裁。加入Teleflex前，2002年10月至2009年8月，他在医疗设备公司Hill-Rom Holdings, Inc.担任多个高级职位，其中，2006年8月至2009年2月担任国际市场营销和研发部副总裁。
- Liam Kelly,has been Teleflex Incorporated President and Chief Executive Officer since January 2018 and has been Chairman of Teleflex Incorporated Board of Directors since May 2020. From May 2016 to December 31, 2017, Mr. Kelly served as Teleflex Incorporated President and Chief Operating Officer. From April 2015 to April 2016, he served as Executive Vice President and Chief Operating Officer. From April 2014 to April 2015, Mr. Kelly served as Executive Vice President and President, Americas. From June 2012 to April 2014 Mr. Kelly served as Executive Vice President and President, International. He also has held several positions with regard to Teleflex Incorporated EMEA segment, including President from June 2011 to June 2012, Executive Vice President from November 2009 to June 2011, and Vice President of Marketing from April 2009 to November 2009. Prior to joining Teleflex, Mr. Kelly held various senior level positions with Hill-Rom Holdings, Inc., a medical device company, from October 2002 to April 2009, serving as its Vice President of International Marketing and R&D from August 2006 to February 2009.
- Candace H. Duncan
-
Candace H. Duncan，自2015年起担任Teleflex董事，目前担任审计委员会主席。她在KPMG LLP（一家公共会计公司）工作了35年，于2013年11月退休。从2009年到退休，她是KPMG's Washington的管理合伙人，并担任KPMG董事会成员。早些时候，她曾在KPMG担任各种职务，包括负责大西洋中部地区审计的管理合伙人和负责KPMG弗吉尼亚州业务部门的审计合伙人。她目前是Discover Financial Services的董事。
Candace H. Duncan,Retired managing partner of the Washington, D.C. metropolitan area of KPMG LLP, a global network of professional firms providing audit, tax, and advisory services, serving until November 2013; Member of KPMG board of directors from 2009 to 2013; Served as chair of the KPMG board's nominating committee, as well as the partnership and employer of choice committee; Served in various roles at KPMG, including managing partner for audit for the Mid-Atlantic area and audit partner in charge for the Virginia business unit. - Candace H. Duncan，自2015年起担任Teleflex董事，目前担任审计委员会主席。她在KPMG LLP（一家公共会计公司）工作了35年，于2013年11月退休。从2009年到退休，她是KPMG's Washington的管理合伙人，并担任KPMG董事会成员。早些时候，她曾在KPMG担任各种职务，包括负责大西洋中部地区审计的管理合伙人和负责KPMG弗吉尼亚州业务部门的审计合伙人。她目前是Discover Financial Services的董事。
- Candace H. Duncan,Retired managing partner of the Washington, D.C. metropolitan area of KPMG LLP, a global network of professional firms providing audit, tax, and advisory services, serving until November 2013; Member of KPMG board of directors from 2009 to 2013; Served as chair of the KPMG board's nominating committee, as well as the partnership and employer of choice committee; Served in various roles at KPMG, including managing partner for audit for the Mid-Atlantic area and audit partner in charge for the Virginia business unit.
- John C. Heinmiller
-
John C. Heinmiller自2019年以来一直担任Teleflex的董事，目前担任审计委员会成员。 在2017年1月退休之前，Heinmiller先生曾担任St. Jude Medical，Inc.的执行副总裁。 全球医疗设备公司Jude Medical”。 Heinmiller先生在圣裘德医疗（St. Jude Medical）工作的19年期间，曾担任各种行政和高级职位，包括2012年8月至2017年1月的执行副总裁； 2004年5月至2012年8月为执行副总裁兼首席财务官； 1998年9月至2004年5月，担任财务副总裁兼首席财务官； 1998年5月至1998年9月担任公司业务发展副总裁。在加入圣裘德医疗公司之前，Heinmiller先生曾在医疗设备公司Daig Corporation和LifeCore担任高级管理职务，并担任董事会成员。 生物医学，一家医疗技术公司。
John C. Heinmiller, has been a director of Teleflex since 2019 and currently serves as a member of the Audit Committee. Prior to his retirement in January 2017 Mr. Heinmiller was Executive Vice President of St. Jude Medical, Inc. "St. Jude Medical", a global medical device company. During his 19-year career with St. Jude Medical, Mr. Heinmiller served in various executive and senior level positions, including Executive Vice President from August 2012 to January 2017; Executive Vice President and Chief Financial Officer from May 2004 to August 2012; Vice President, Finance and Chief Financial Officer from September 1998 to May 2004; and Vice President of Corporate Business Development from May 1998 to September 1998. Prior to joining St. Jude Medical, Mr. Heinmiller held senior management positions with and was a member of the board of directors of Daig Corporation, a medical device company, and LifeCore Biomedical, a medical technology company. - John C. Heinmiller自2019年以来一直担任Teleflex的董事，目前担任审计委员会成员。 在2017年1月退休之前，Heinmiller先生曾担任St. Jude Medical，Inc.的执行副总裁。 全球医疗设备公司Jude Medical”。 Heinmiller先生在圣裘德医疗（St. Jude Medical）工作的19年期间，曾担任各种行政和高级职位，包括2012年8月至2017年1月的执行副总裁； 2004年5月至2012年8月为执行副总裁兼首席财务官； 1998年9月至2004年5月，担任财务副总裁兼首席财务官； 1998年5月至1998年9月担任公司业务发展副总裁。在加入圣裘德医疗公司之前，Heinmiller先生曾在医疗设备公司Daig Corporation和LifeCore担任高级管理职务，并担任董事会成员。 生物医学，一家医疗技术公司。
- John C. Heinmiller, has been a director of Teleflex since 2019 and currently serves as a member of the Audit Committee. Prior to his retirement in January 2017 Mr. Heinmiller was Executive Vice President of St. Jude Medical, Inc. "St. Jude Medical", a global medical device company. During his 19-year career with St. Jude Medical, Mr. Heinmiller served in various executive and senior level positions, including Executive Vice President from August 2012 to January 2017; Executive Vice President and Chief Financial Officer from May 2004 to August 2012; Vice President, Finance and Chief Financial Officer from September 1998 to May 2004; and Vice President of Corporate Business Development from May 1998 to September 1998. Prior to joining St. Jude Medical, Mr. Heinmiller held senior management positions with and was a member of the board of directors of Daig Corporation, a medical device company, and LifeCore Biomedical, a medical technology company.
- Neena M. Patil
-
Neena M. Patil，是新的董事提名人。 自 2021 年 2 月起，她担任Jazz Pharmaceuticals plc 的首席法务官兼法律和公司事务高级副总裁。 从 2019 年 7 月到 2021 年 2 月，Patil 女士担任 Jazz Pharmaceuticals 的高级副总裁兼总法律顾问。 在加入 Jazz Pharmaceuticals 之前，Patil 女士于 2018 年 9 月至 2019 年 7 月担任临床阶段生物制药公司 Abeona Therapeutics Inc. 的高级副总裁、总法律顾问和公司秘书。在此之前，从 2008 年 5 月至 2016 年 10 月，Ms。 。 Patil 在 Novo Nordisk Inc. 担任过多个管理职位，最终担任法律事务副总裁和副总法律顾问。 在 2008 年之前，她曾在其他几家全球生物制药公司工作，包括辉瑞公司、GPC Biotech AG 和赛诺菲。
Neena M. Patil,was appointed Jazz Pharmaceuticals Public Limited Company Executive Vice President and Chief Legal Officer as of August 2022. Ms. Patil joined Jazz Pharmaceuticals as Senior Vice President and General Counsel in July 2019. From September 2018 to July 2019, Ms. Patil served as Senior Vice President, General Counsel and Corporate Secretary of Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company. Prior to that, from May 2008 to October 2016, Ms. Patil served in management positions at Novo Nordisk Inc., culminating in her role as Vice President for Legal Affairs and Associate General Counsel. Prior to 2008, she worked for several other global biopharmaceutical companies including Pfizer, GPC Biotech and Sanofi. Ms. Patil serves on the board of directors of Teleflex, Inc., a global provider of medical technologies. Ms. Patil also serves on the U.S. Board of Mothers 2 Mothers, a global health care organization operating in Africa. Ms. Patil received a B.A. from Georgetown University and a J.D. and Master of Health Services Administration from the University of Michigan. - Neena M. Patil，是新的董事提名人。 自 2021 年 2 月起，她担任Jazz Pharmaceuticals plc 的首席法务官兼法律和公司事务高级副总裁。 从 2019 年 7 月到 2021 年 2 月，Patil 女士担任 Jazz Pharmaceuticals 的高级副总裁兼总法律顾问。 在加入 Jazz Pharmaceuticals 之前，Patil 女士于 2018 年 9 月至 2019 年 7 月担任临床阶段生物制药公司 Abeona Therapeutics Inc. 的高级副总裁、总法律顾问和公司秘书。在此之前，从 2008 年 5 月至 2016 年 10 月，Ms。 。 Patil 在 Novo Nordisk Inc. 担任过多个管理职位，最终担任法律事务副总裁和副总法律顾问。 在 2008 年之前，她曾在其他几家全球生物制药公司工作，包括辉瑞公司、GPC Biotech AG 和赛诺菲。
- Neena M. Patil,was appointed Jazz Pharmaceuticals Public Limited Company Executive Vice President and Chief Legal Officer as of August 2022. Ms. Patil joined Jazz Pharmaceuticals as Senior Vice President and General Counsel in July 2019. From September 2018 to July 2019, Ms. Patil served as Senior Vice President, General Counsel and Corporate Secretary of Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company. Prior to that, from May 2008 to October 2016, Ms. Patil served in management positions at Novo Nordisk Inc., culminating in her role as Vice President for Legal Affairs and Associate General Counsel. Prior to 2008, she worked for several other global biopharmaceutical companies including Pfizer, GPC Biotech and Sanofi. Ms. Patil serves on the board of directors of Teleflex, Inc., a global provider of medical technologies. Ms. Patil also serves on the U.S. Board of Mothers 2 Mothers, a global health care organization operating in Africa. Ms. Patil received a B.A. from Georgetown University and a J.D. and Master of Health Services Administration from the University of Michigan.
- Jaewon Ryu
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Stuart A. Randle
-
Stuart A. Randle，自2009年以来，他一直担任泰利福公司的董事，目前作为薪酬委员会的成员。先生自2004年2月以来，他担任GI Dynamics公司的总裁兼首席执行官，这是一家医疗设备公司。从2003年到2004年，他担任Optobionics公司的临时首席执行官。从2002年到2003年，他担任先进技术企业的企业家，一家医疗和风险资本公司。从1998年到2001年，他担任Act Medical的总裁兼首席执行官，1998年之前Randle先生担任忠诚医疗公司高级管理职位和巴克斯特国际公司的高管职位。Randle先生目前担任Beacon Roofing Supply公司的董事成员和先进医疗技术协会的董事会成员。
Stuart A. Randle, has been a director of Teleflex since 2009 and currently serves as chair of the Nominating and Governance Committee and as a member of the Compensation Committee. Mr. Randle retired in December 2018 after serving for three years as the Chief Executive Officer of Ivenix, Inc., a medical device company that provides infusion delivery systems. Previously, Mr. Randle had been retired since September 2014 after serving for 10 years as President and Chief Executive Officer of GI Dynamics, Inc., a medical device company. From 2003 to 2004 he served as Interim Chief Executive Officer of Optobionics Corporation, a medical device company. From 2002 to 2003 Mr. Randle held the position of Entrepreneur in Residence of Advanced Technology Ventures, a healthcare and information technology venture capital firm. From 1998 to 2001 he was President and Chief Executive Officer of Act Medical, Inc. Prior to 1998 Mr. Randle held various senior management positions with Allegiance Healthcare Corporation and Baxter International Inc. Mr. Randle currently serves as a director of Beacon Roofing Supply, Inc. - Stuart A. Randle，自2009年以来，他一直担任泰利福公司的董事，目前作为薪酬委员会的成员。先生自2004年2月以来，他担任GI Dynamics公司的总裁兼首席执行官，这是一家医疗设备公司。从2003年到2004年，他担任Optobionics公司的临时首席执行官。从2002年到2003年，他担任先进技术企业的企业家，一家医疗和风险资本公司。从1998年到2001年，他担任Act Medical的总裁兼首席执行官，1998年之前Randle先生担任忠诚医疗公司高级管理职位和巴克斯特国际公司的高管职位。Randle先生目前担任Beacon Roofing Supply公司的董事成员和先进医疗技术协会的董事会成员。
- Stuart A. Randle, has been a director of Teleflex since 2009 and currently serves as chair of the Nominating and Governance Committee and as a member of the Compensation Committee. Mr. Randle retired in December 2018 after serving for three years as the Chief Executive Officer of Ivenix, Inc., a medical device company that provides infusion delivery systems. Previously, Mr. Randle had been retired since September 2014 after serving for 10 years as President and Chief Executive Officer of GI Dynamics, Inc., a medical device company. From 2003 to 2004 he served as Interim Chief Executive Officer of Optobionics Corporation, a medical device company. From 2002 to 2003 Mr. Randle held the position of Entrepreneur in Residence of Advanced Technology Ventures, a healthcare and information technology venture capital firm. From 1998 to 2001 he was President and Chief Executive Officer of Act Medical, Inc. Prior to 1998 Mr. Randle held various senior management positions with Allegiance Healthcare Corporation and Baxter International Inc. Mr. Randle currently serves as a director of Beacon Roofing Supply, Inc.
- Andrew A. Krakauer
-
Andrew A. Krakauer自2018年起担任Teleflex董事，目前担任薪酬委员会成员。在2016年10月退休之前，Krakauer先生是Cantel Medical Corp.“Cantel”的首席执行官，Cantel Medical Corp.是一家感染控制产品和服务供应商。在Cantel工作的12年间，Krakauer先生担任过多个行政和高级职位，包括2014年11月至2016年7月担任首席执行官；2009年3月至2014年11月担任总裁兼首席执行官；2008年4月至2009年3月担任总裁；2004年8月至2008年4月担任执行副总裁兼首席运营官。2009年至2016年，Krakauer还担任Cantel董事会成员。在加入Cantel之前，Krakauer先生于1998年至2004年担任医疗设备供应商Instrumentarium Corp.（Instrumentarium Corp.于2003年被General Electric Company收购）Ohmeda医疗部的总裁。Krakauer先生目前担任KL Acquisition公司董事。
Andrew A. Krakauer, has been a director of Teleflex since 2018 and currently serves as a member of the Compensation Committee. Prior to his retirement in October 2016 Mr. Krakauer was Chief Executive Officer of Cantel Medical Corp. "Cantel", a provider of infection control products and services. During his 12 years at Cantel, Mr. Krakauer served in various executive and senior level positions, including Chief Executive Officer from November 2014 to July 2016; President and Chief Executive Officer from March 2009 to November 2014; President from April 2008 to March 2009; and Executive Vice President and Chief Operating Officer from August 2004 through April 2008. Mr. Krakauer also served as a member of Cantel's board of directors from 2009 to 2016. Prior to joining Cantel, Mr. Krakauer was President of the Ohmeda Medical Division of Instrumentarium Corp. (which was acquired by General Electric Company in 2003), a provider of medical devices, from 1998 to 2004. Mr. Krakauer currently serves as a director of KL Acquisition Corp. - Andrew A. Krakauer自2018年起担任Teleflex董事，目前担任薪酬委员会成员。在2016年10月退休之前，Krakauer先生是Cantel Medical Corp.“Cantel”的首席执行官，Cantel Medical Corp.是一家感染控制产品和服务供应商。在Cantel工作的12年间，Krakauer先生担任过多个行政和高级职位，包括2014年11月至2016年7月担任首席执行官；2009年3月至2014年11月担任总裁兼首席执行官；2008年4月至2009年3月担任总裁；2004年8月至2008年4月担任执行副总裁兼首席运营官。2009年至2016年，Krakauer还担任Cantel董事会成员。在加入Cantel之前，Krakauer先生于1998年至2004年担任医疗设备供应商Instrumentarium Corp.（Instrumentarium Corp.于2003年被General Electric Company收购）Ohmeda医疗部的总裁。Krakauer先生目前担任KL Acquisition公司董事。
- Andrew A. Krakauer, has been a director of Teleflex since 2018 and currently serves as a member of the Compensation Committee. Prior to his retirement in October 2016 Mr. Krakauer was Chief Executive Officer of Cantel Medical Corp. "Cantel", a provider of infection control products and services. During his 12 years at Cantel, Mr. Krakauer served in various executive and senior level positions, including Chief Executive Officer from November 2014 to July 2016; President and Chief Executive Officer from March 2009 to November 2014; President from April 2008 to March 2009; and Executive Vice President and Chief Operating Officer from August 2004 through April 2008. Mr. Krakauer also served as a member of Cantel's board of directors from 2009 to 2016. Prior to joining Cantel, Mr. Krakauer was President of the Ohmeda Medical Division of Instrumentarium Corp. (which was acquired by General Electric Company in 2003), a provider of medical devices, from 1998 to 2004. Mr. Krakauer currently serves as a director of KL Acquisition Corp.
- Stephen K. Klasko
-
Stephen K. Klasko，他2008年起担任Teleflex的董事，现任审计委员会成员。2013年6月起，他担任Thomas Jefferson University的校长，以及Thomas Jefferson University Hospitals System的总裁和首席执行官。2004年9月至2013年6月，他担任University of South Florida医学院院长。2009至2013年6月，他还担任USF Health的首席执行官，它包括University of South Florida的医学、护理和公共健康学院。他2004至2009年担任USF Health的副总裁。2000至2004年他也是Drexel University的医学院院长。
Stephen K. Klasko, has been a director of Teleflex since 2008 and currently serves as a member of the Nominating and Governance Committee. Dr. Klasko retired in December 2021 after serving as President of Thomas Jefferson University and Chief executive Officer of Jefferson Health. In connection with his retirement transition, Dr. Klasko has agreed to serve as a special advisor to the Jefferson Board of Trustees until June 2022. From September 2004 to June 2013 Dr. Klasko served as Dean of the College of Medicine of the University of South Florida. From 2009 to June 2013 Dr. Klasko also served as the Chief Executive Officer of USF Health, which encompasses the University of South Florida's colleges of medicine, nursing and public health. He was a Vice President of USF Health from 2004 to 2009. Dr. Klasko served as Dean of the College of Medicine of Drexel University from 2000 to 2004. Dr. Klasko also serves as a director of Health Assurance Acquisition Corp. - Stephen K. Klasko，他2008年起担任Teleflex的董事，现任审计委员会成员。2013年6月起，他担任Thomas Jefferson University的校长，以及Thomas Jefferson University Hospitals System的总裁和首席执行官。2004年9月至2013年6月，他担任University of South Florida医学院院长。2009至2013年6月，他还担任USF Health的首席执行官，它包括University of South Florida的医学、护理和公共健康学院。他2004至2009年担任USF Health的副总裁。2000至2004年他也是Drexel University的医学院院长。
- Stephen K. Klasko, has been a director of Teleflex since 2008 and currently serves as a member of the Nominating and Governance Committee. Dr. Klasko retired in December 2021 after serving as President of Thomas Jefferson University and Chief executive Officer of Jefferson Health. In connection with his retirement transition, Dr. Klasko has agreed to serve as a special advisor to the Jefferson Board of Trustees until June 2022. From September 2004 to June 2013 Dr. Klasko served as Dean of the College of Medicine of the University of South Florida. From 2009 to June 2013 Dr. Klasko also served as the Chief Executive Officer of USF Health, which encompasses the University of South Florida's colleges of medicine, nursing and public health. He was a Vice President of USF Health from 2004 to 2009. Dr. Klasko served as Dean of the College of Medicine of Drexel University from 2000 to 2004. Dr. Klasko also serves as a director of Health Assurance Acquisition Corp.
- Gretchen R. Haggerty
-
Gretchen R. Haggerty， 她于2013年8月退任nited States Steel Corporation的执行副总裁兼首席财务官（任职5年以上）。她是the Strategic Investment Fund，以及the Pennsylvania Business Council的董事。2011年5月以来，她一直担任董事。她是董事会的审计和财政委员会的成员。
Gretchen R. Haggerty,retired in August 2013 after a 37-year career with United States Steel Corporation, an integrated global steel producer, and its predecessor, USX Corporation, which, in addition to its steel production, also managed and supervised energy operations, principally through Marathon Oil Corporation. From March 2003 until her retirement, Ms. Haggerty served as Executive Vice President & Chief Financial Officer and also served as Chairman of the U. S. Steel & Carnegie Pension Fund and its Investment Committee. Earlier, she served in various financial executive positions at U. S. Steel and USX, beginning in November 1991 when she became Vice President & Treasurer. Ms. Haggerty is currently a Director of Teleflex Incorporated, a global provider of medical technology products, and is a former Director of USG Corporation, a leading manufacturer of building materials. - Gretchen R. Haggerty， 她于2013年8月退任nited States Steel Corporation的执行副总裁兼首席财务官（任职5年以上）。她是the Strategic Investment Fund，以及the Pennsylvania Business Council的董事。2011年5月以来，她一直担任董事。她是董事会的审计和财政委员会的成员。
- Gretchen R. Haggerty,retired in August 2013 after a 37-year career with United States Steel Corporation, an integrated global steel producer, and its predecessor, USX Corporation, which, in addition to its steel production, also managed and supervised energy operations, principally through Marathon Oil Corporation. From March 2003 until her retirement, Ms. Haggerty served as Executive Vice President & Chief Financial Officer and also served as Chairman of the U. S. Steel & Carnegie Pension Fund and its Investment Committee. Earlier, she served in various financial executive positions at U. S. Steel and USX, beginning in November 1991 when she became Vice President & Treasurer. Ms. Haggerty is currently a Director of Teleflex Incorporated, a global provider of medical technology products, and is a former Director of USG Corporation, a leading manufacturer of building materials.
高管简历
中英对照 | 中文 | 英文- Liam Kelly
Liam Kelly，2012年6月起担任执行副总裁和国际总裁。此前，他在公司EMEA部担任数个职位，包括2011年6月至2012年6月任总裁；2009年11月至2011年6月任执行副总裁；2009年4月至11月任市场营销副总裁。加入Teleflex前，2002年10月至2009年8月，他在医疗设备公司Hill-Rom Holdings, Inc.担任多个高级职位，其中，2006年8月至2009年2月担任国际市场营销和研发部副总裁。
Liam Kelly,has been Teleflex Incorporated President and Chief Executive Officer since January 2018 and has been Chairman of Teleflex Incorporated Board of Directors since May 2020. From May 2016 to December 31, 2017, Mr. Kelly served as Teleflex Incorporated President and Chief Operating Officer. From April 2015 to April 2016, he served as Executive Vice President and Chief Operating Officer. From April 2014 to April 2015, Mr. Kelly served as Executive Vice President and President, Americas. From June 2012 to April 2014 Mr. Kelly served as Executive Vice President and President, International. He also has held several positions with regard to Teleflex Incorporated EMEA segment, including President from June 2011 to June 2012, Executive Vice President from November 2009 to June 2011, and Vice President of Marketing from April 2009 to November 2009. Prior to joining Teleflex, Mr. Kelly held various senior level positions with Hill-Rom Holdings, Inc., a medical device company, from October 2002 to April 2009, serving as its Vice President of International Marketing and R&D from August 2006 to February 2009.- Liam Kelly，2012年6月起担任执行副总裁和国际总裁。此前，他在公司EMEA部担任数个职位，包括2011年6月至2012年6月任总裁；2009年11月至2011年6月任执行副总裁；2009年4月至11月任市场营销副总裁。加入Teleflex前，2002年10月至2009年8月，他在医疗设备公司Hill-Rom Holdings, Inc.担任多个高级职位，其中，2006年8月至2009年2月担任国际市场营销和研发部副总裁。
- Liam Kelly,has been Teleflex Incorporated President and Chief Executive Officer since January 2018 and has been Chairman of Teleflex Incorporated Board of Directors since May 2020. From May 2016 to December 31, 2017, Mr. Kelly served as Teleflex Incorporated President and Chief Operating Officer. From April 2015 to April 2016, he served as Executive Vice President and Chief Operating Officer. From April 2014 to April 2015, Mr. Kelly served as Executive Vice President and President, Americas. From June 2012 to April 2014 Mr. Kelly served as Executive Vice President and President, International. He also has held several positions with regard to Teleflex Incorporated EMEA segment, including President from June 2011 to June 2012, Executive Vice President from November 2009 to June 2011, and Vice President of Marketing from April 2009 to November 2009. Prior to joining Teleflex, Mr. Kelly held various senior level positions with Hill-Rom Holdings, Inc., a medical device company, from October 2002 to April 2009, serving as its Vice President of International Marketing and R&D from August 2006 to February 2009.
- Cameron P. Hicks
Cameron P. Hicks2013年4月起担任Teleflex Incorporated公司人力资源和通信副总裁。加入Teleflex之前，2010年7月至2013年3月，他担任Harlan Laboratories, Inc.（临床前和非临床研究服务的私人全球供应商）的人力资源和组织有效性执行副总裁。1990年4月至2010年1月，他在MDS公司担任各种领导职务，MDS公司是药物开发和疾病诊断和治疗的产品和服务提供商，包括2000年11月至2010年1月MDS全球制药服务部门的人力资源高级副总裁。
Cameron P. Hicks,has been Teleflex Incorporated Corporate Vice President, Human Resources and Communications since April 2013. Prior to joining Teleflex, Mr. Hicks served as Executive Vice President of Human Resources & Organizational Effectiveness for Harlan Laboratories, Inc., a private global provider of pre-clinical and non-clinical research services, from July 2010 to March 2013. From April 1990 to January 2010, Mr. Hicks held various leadership roles with MDS Inc., a provider of products and services for the development of drugs and the diagnosis and treatment of disease, including Senior Vice President of Human Resources for MDS' global Pharma Services division from November 2000 to January 2010.- Cameron P. Hicks2013年4月起担任Teleflex Incorporated公司人力资源和通信副总裁。加入Teleflex之前，2010年7月至2013年3月，他担任Harlan Laboratories, Inc.（临床前和非临床研究服务的私人全球供应商）的人力资源和组织有效性执行副总裁。1990年4月至2010年1月，他在MDS公司担任各种领导职务，MDS公司是药物开发和疾病诊断和治疗的产品和服务提供商，包括2000年11月至2010年1月MDS全球制药服务部门的人力资源高级副总裁。
- Cameron P. Hicks,has been Teleflex Incorporated Corporate Vice President, Human Resources and Communications since April 2013. Prior to joining Teleflex, Mr. Hicks served as Executive Vice President of Human Resources & Organizational Effectiveness for Harlan Laboratories, Inc., a private global provider of pre-clinical and non-clinical research services, from July 2010 to March 2013. From April 1990 to January 2010, Mr. Hicks held various leadership roles with MDS Inc., a provider of products and services for the development of drugs and the diagnosis and treatment of disease, including Senior Vice President of Human Resources for MDS' global Pharma Services division from November 2000 to January 2010.
- John R. Deren
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- James Winters
James Winters，自2020年2月起担任Teleflex Incorporated制造和供应链副总裁。他曾于2018年3月至2020年1月担任全球制造副总裁。在加入Teleflex之前，Winters先生于2005年8月至2018年2月在医疗保健公司DePuy Synthes部门担任过多个高级管理和运营职务。最近，Winters先生于2015年2月至2018年2月担任DePuy Synthes全球联合重组全球制造副总裁。在此之前，Winters先生担任DePuy Synthes爱尔兰制造业务的工厂经理。
James Winters,has been Teleflex Incorporated Corporate Vice President, Manufacturing and Supply Chain since February 2020. He previously held the position of Vice President, Global Manufacturing from March 2018 to January 2020. Prior to joining Teleflex, Mr. Winters held various senior management and operational roles with the DePuy Synthes division of Johnson & Johnson, a healthcare company, from August 2005 to February 2018. Most recently, Mr. Winters served as Vice President of Global Manufacturing for Global Joint Reconstruction for DePuy Synthes from February 2015 to February 2018. Prior to that, Mr. Winters served as Plant Manager for the DePuy Synthes Ireland Manufacturing Operation.- James Winters，自2020年2月起担任Teleflex Incorporated制造和供应链副总裁。他曾于2018年3月至2020年1月担任全球制造副总裁。在加入Teleflex之前，Winters先生于2005年8月至2018年2月在医疗保健公司DePuy Synthes部门担任过多个高级管理和运营职务。最近，Winters先生于2015年2月至2018年2月担任DePuy Synthes全球联合重组全球制造副总裁。在此之前，Winters先生担任DePuy Synthes爱尔兰制造业务的工厂经理。
- James Winters,has been Teleflex Incorporated Corporate Vice President, Manufacturing and Supply Chain since February 2020. He previously held the position of Vice President, Global Manufacturing from March 2018 to January 2020. Prior to joining Teleflex, Mr. Winters held various senior management and operational roles with the DePuy Synthes division of Johnson & Johnson, a healthcare company, from August 2005 to February 2018. Most recently, Mr. Winters served as Vice President of Global Manufacturing for Global Joint Reconstruction for DePuy Synthes from February 2015 to February 2018. Prior to that, Mr. Winters served as Plant Manager for the DePuy Synthes Ireland Manufacturing Operation.
- Daniel V. Logue
Daniel V. Logue，他一直担任Teleflex Incorporated副总裁、总法律顾问和秘书（2021年1月以来）。Logue先生于2004年加入Teleflex，此前曾担任副总法律顾问（2017年2月至2020年12月），副总法律顾问（2013年3月至2017年1月），助理总法律顾问（2004年6月至2013年2月）。加入Teleflex之前，1999年9月至2004年6月，Logue先生是律师事务所Pepper Hamilton LLP（现为Troutman Pepper Hamilton Sanders LLP）的助理。
Daniel V. Logue,has been Teleflex Incorporated Corporate Vice President, General Counsel and Secretary since January 2021. Mr. Logue joined Teleflex in 2004 and previously held the positions of Deputy General Counsel from February 2017 to December 2020, Associate General Counsel from March 2013 to January 2017 and Assistant General Counsel from June 2004 to February 2013. Prior to joining Teleflex, Mr. Logue was an associate at the law firm of Pepper Hamilton LLP (now Troutman Pepper Hamilton Sanders LLP) from September 1999 to June 2004.- Daniel V. Logue，他一直担任Teleflex Incorporated副总裁、总法律顾问和秘书（2021年1月以来）。Logue先生于2004年加入Teleflex，此前曾担任副总法律顾问（2017年2月至2020年12月），副总法律顾问（2013年3月至2017年1月），助理总法律顾问（2004年6月至2013年2月）。加入Teleflex之前，1999年9月至2004年6月，Logue先生是律师事务所Pepper Hamilton LLP（现为Troutman Pepper Hamilton Sanders LLP）的助理。
- Daniel V. Logue,has been Teleflex Incorporated Corporate Vice President, General Counsel and Secretary since January 2021. Mr. Logue joined Teleflex in 2004 and previously held the positions of Deputy General Counsel from February 2017 to December 2020, Associate General Counsel from March 2013 to January 2017 and Assistant General Counsel from June 2004 to February 2013. Prior to joining Teleflex, Mr. Logue was an associate at the law firm of Pepper Hamilton LLP (now Troutman Pepper Hamilton Sanders LLP) from September 1999 to June 2004.
- Jay White
Jay White自2021年2月起担任Teleflex Incorporated副总裁兼全球商业总裁。从2017年2月到2021年1月，他担任Teleflex Incorporated的总裁，负责美洲业务；从2013年12月到2017年1月，他担任Vascular的总裁和总经理。从2013年1月到2013年11月，他担任Teleflex Incorporated的外科总裁和总经理。在此之前，他从2010年1月到2012年12月担任Teleflex Incorporated的外科副总裁和总经理。他于2005年3月加入Teleflex，担任Teleflex Incorporated北美市场营销总监。加入Teleflex之前，他曾任职Covidien plc（现在是Medtronic plc的一部分），在那里他曾担任销售和营销的高级领导职位超过5年。
Jay White,has been Teleflex Incorporated Corporate Vice President and President, Global Commercial since February 2021. From February 2017 to January 2021, Mr. White served as Teleflex Incorporated President, The Americas, and from December 2013 to January 2017 he served as President and General Manager, Vascular. From January 2013 to November 2013, Mr. White served as Teleflex Incorporated President and General Manager, Surgical. Prior to that, he served as Teleflex Incorporated Vice President and General Manager, Surgical from January 2010 to December 2012. Mr. White joined Teleflex in March 2005 as Teleflex Incorporated Director of Marketing, North America. Prior to joining Teleflex, Mr. White worked at Covidien plc (now part of Medtronic plc) where he held senior leadership positions in sales and marketing over a five-year period.- Jay White自2021年2月起担任Teleflex Incorporated副总裁兼全球商业总裁。从2017年2月到2021年1月，他担任Teleflex Incorporated的总裁，负责美洲业务；从2013年12月到2017年1月，他担任Vascular的总裁和总经理。从2013年1月到2013年11月，他担任Teleflex Incorporated的外科总裁和总经理。在此之前，他从2010年1月到2012年12月担任Teleflex Incorporated的外科副总裁和总经理。他于2005年3月加入Teleflex，担任Teleflex Incorporated北美市场营销总监。加入Teleflex之前，他曾任职Covidien plc（现在是Medtronic plc的一部分），在那里他曾担任销售和营销的高级领导职位超过5年。
- Jay White,has been Teleflex Incorporated Corporate Vice President and President, Global Commercial since February 2021. From February 2017 to January 2021, Mr. White served as Teleflex Incorporated President, The Americas, and from December 2013 to January 2017 he served as President and General Manager, Vascular. From January 2013 to November 2013, Mr. White served as Teleflex Incorporated President and General Manager, Surgical. Prior to that, he served as Teleflex Incorporated Vice President and General Manager, Surgical from January 2010 to December 2012. Mr. White joined Teleflex in March 2005 as Teleflex Incorporated Director of Marketing, North America. Prior to joining Teleflex, Mr. White worked at Covidien plc (now part of Medtronic plc) where he held senior leadership positions in sales and marketing over a five-year period.
- Thomas E. Powell
Thomas E. Powell，2013年2月起担任执行副总裁和首席财务官。2012年3月至2013年2月，他担任高级副总裁和首席财务官。他2011年8月加入Teleflex，担任全球财务部高级副总裁。加入Teleflex前，2009年6月至2011年6月，他担任医疗设备公司Tomotherapy Incorporated首席财务官和财务负责人。2008年他担任软件供应商Textura Corporation的首席财务官。2001年4月至2008年1月，他受雇于软件供应商Midway Games, Inc.，2001年9月至2008年1月期间担任其执行副总裁、首席财务官和财务负责人。他还在Dade Behring, Inc（现Siemens Healthcare Diagnostics）， PepsiCo, Bain & Company, Tenneco Inc.以及Arthur Andersen & Company。担任领导职位。
Thomas E. Powell,has been Teleflex Incorporated Executive Vice President and Chief Financial Officer since February 2013. From March 2012 to February 2013, Mr. Powell was Senior Vice President and Chief Financial Officer. He joined Teleflex in August 2011 as Senior Vice President, Global Finance. Prior to joining Teleflex, Mr. Powell served as Chief Financial Officer and Treasurer of Tomotherapy Incorporated, a medical device company, from June 2009 until June 2011. In 2008, he served as Chief Financial Officer of Textura Corporation, a software provider. From April 2001 until January 2008, Mr. Powell was employed by Midway Games, Inc., a software provider, serving as its Executive Vice President, Chief Financial Officer and Treasurer from September 2001 until January 2008. Mr. Powell has also held leadership positions with Dade Behring, Inc., PepsiCo, Bain & Company, Tenneco Inc. and Arthur Andersen & Company.- Thomas E. Powell，2013年2月起担任执行副总裁和首席财务官。2012年3月至2013年2月，他担任高级副总裁和首席财务官。他2011年8月加入Teleflex，担任全球财务部高级副总裁。加入Teleflex前，2009年6月至2011年6月，他担任医疗设备公司Tomotherapy Incorporated首席财务官和财务负责人。2008年他担任软件供应商Textura Corporation的首席财务官。2001年4月至2008年1月，他受雇于软件供应商Midway Games, Inc.，2001年9月至2008年1月期间担任其执行副总裁、首席财务官和财务负责人。他还在Dade Behring, Inc（现Siemens Healthcare Diagnostics）， PepsiCo, Bain & Company, Tenneco Inc.以及Arthur Andersen & Company。担任领导职位。
- Thomas E. Powell,has been Teleflex Incorporated Executive Vice President and Chief Financial Officer since February 2013. From March 2012 to February 2013, Mr. Powell was Senior Vice President and Chief Financial Officer. He joined Teleflex in August 2011 as Senior Vice President, Global Finance. Prior to joining Teleflex, Mr. Powell served as Chief Financial Officer and Treasurer of Tomotherapy Incorporated, a medical device company, from June 2009 until June 2011. In 2008, he served as Chief Financial Officer of Textura Corporation, a software provider. From April 2001 until January 2008, Mr. Powell was employed by Midway Games, Inc., a software provider, serving as its Executive Vice President, Chief Financial Officer and Treasurer from September 2001 until January 2008. Mr. Powell has also held leadership positions with Dade Behring, Inc., PepsiCo, Bain & Company, Tenneco Inc. and Arthur Andersen & Company.